Home
Companies
Catalysts
Deep Dives
BPDCN
BPDCN · Oncology · 1 drugs · 1 indications
Competitive Landscape (1 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Pivekimab sunirine
ABBV
CD123-targeting ADC
ADC
IV
FILED
Indications (1)
BPDCN
Pivekimab sunirine
FILED
Upcoming Catalysts
Pivekimab Sunirine - BPDCN - FDA Approval
REGULATORY
ABBV
2026
Data from Supabase · Updated 2026-03-24